VISHEE(SH:688580) Shang Hai Zheng Quan Bao·2025-11-04 19:02Core Viewpoint - The announcement details a change in shareholding by a major shareholder of Nanjing Weisi Medical Technology Co., Ltd., indicating a reduction in their stake, which has implications for the company's governance and shareholder structure [1][2][3] Group 1: Shareholder Information - The major shareholder, Wang Zhiyu, and his acting party, Nanjing Zhida Venture Capital Center (Limited Partnership), have confirmed the accuracy and completeness of the information provided [1] - Wang Zhiyu serves as the executive partner and general partner of Nanjing Zhida Venture Capital Center, which has signed a concerted action agreement with him [1] Group 2: Equity Change Details - From August 14 to November 4, 2025, Nanjing Zhida Venture Capital Center reduced its shareholding by 728,210 shares, representing 0.76% of the total share capital [1] - Following this reduction, the combined shareholding of Wang Zhiyu and Nanjing Zhida Venture Capital Center decreased from 45,723,286 shares to 44,995,076 shares, which is a drop from 47.74% to 46.98% of the total share capital [2] Group 3: Additional Notes - The equity change does not trigger a mandatory tender offer and aligns with previously disclosed plans by the information disclosure obligor [2][3] - The change in shareholding will not affect the control of the company or its governance structure, and the information disclosure obligor is expected to continue adhering to relevant regulations [3]